Skip to main content
Clinical Trials/ISRCTN57640029
ISRCTN57640029
Completed
Not Applicable

Impact of implementing a surveillance of adverse events associated with totally implanted venous-access ports in cancer inpatients: a quasi-experimental study

French Ministry of Health and Sport (France)0 sites1,000 target enrollmentJanuary 13, 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
French Ministry of Health and Sport (France)
Enrollment
1000
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 13, 2011
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
French Ministry of Health and Sport (France)

Eligibility Criteria

Inclusion Criteria

  • Two hospitals will participate in the study: a university hospital, and a hospital exclusively dedicated to the care of cancer patients. In each hospital, wards performing cancer intravenous chemotherapy as a usual activity will be approached and proposed the implementation of a surveillance of adverse events associated with totally implanted venous\-access ports. Only patients (male or female adults above 18 years old) with totally implanted venous\-access ports used for cancer chemotherapy will be included in this surveillance.

Exclusion Criteria

  • Wards with no, or infrequent, activity of cancer chemotherapy will not be included in the study. In wards participating in the study, patients with totally implanted venous\-access ports used for other treatment than cancer chemotherapy (antibiotics, parenteral nutrition, etc.) will not be included in the surveillance.

Outcomes

Primary Outcomes

Not specified

Similar Trials